Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.

 

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code Company Price % Volume Market Cap
DXN DXN Limited 0.002 100% 500,216 $1,721,315
OAU Ora Gold Limited 0.004 60% 78,313,666 $9,842,313
CLE Cyclone Metals 0.0015 50% 500,668 $10,264,505
LNU Linius Tech Limited 0.004 33% 10,000,000 $11,296,372
ENR Encounter Resources 0.34 28% 4,601,421 $104,814,332
CTO Citigold Corp Ltd 0.005 25% 199,010 $11,494,636
SFG Seafarms Group Ltd 0.005 25% 403,000 $19,346,397
RDN Raiden Resources Ltd 0.0085 21% 24,256,859 $14,386,883
MXC Mgc Pharmaceuticals 0.006 20% 361,238 $16,753,465
SRZ Stellar Resources 0.012 20% 2,176,611 $10,059,642
Wordpress Table Plugin

Ora Gold (ASX:OAU) is reporting a hatful of impressive hits in extensional drilling at the ‘Crown Prince’ prospect, including a highlight 40m at 17.53g/t from 30m.

That’s thick, shallow, and very high grade – three things investors should look for when evaluating drill assay results.

Encounter Resources (ASX:ENR) has intersected niobium-REE mineralised carbonatites over 3.5km at ‘Aileron’, next door to WA1 Resources’ (ASX:WA1) big find.

Raiden Resources (ASX:RDN) has snapped up exploration ground in the Pilbara, right next door to Azure Minerals’ (ASX:AZS) recent lithium discovery (112.4m @ 1.05% Li2O).

And Stellar Resources (ASX:SRZ) has hit a significant 38.6m-long Zn-Pb-Cu mineralised zone at ‘North Scamander’ in Tasmania, from 130m depth.

The exploration hole had reached a depth of 360m on 23 June with a planned EOH depth of 750m.

 

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code Company Price % Volume Market Cap
MCT Metalicity Limited 0.001 -50% 90,000 $7,472,172
IXC Invex Ther 0.23 -49% 1,060,877 $34,195,001
KEY KEY Petroleum 0.001 -33% 250,000 $2,951,892
MTB Mount Burgess Mining 0.001 -33% 289 $1,324,757
FRS Forrestaniaresources 0.105 -30% 4,128,111 $12,752,031
ADR Adherium Ltd 0.002 -20% 370,000 $12,491,096
DDT DataDot Technology 0.002 -20% 166,666 $3,027,382
IVX Invion Ltd 0.004 -20% 13,899 $32,108,161
MRD Mount Ridley Mines 0.002 -20% 256 $19,462,207
1MC Morella Corporation 0.006 -14% 276,154 $42,690,063
Wordpress Table Plugin

Biopharma Invex Therapeutics (ASX:IXC) says slower than anticipated recruitment and delay in site activations has impacted company timelines on recruitment into the IIH EVOLVE trial.

IXC has elected to withdraw guidance relating to the expected recruitment of the IIH EVOLVE trial, which was anticipated at take approximately 24 months from commencement of patient recruitment in Q4 CY2022.

And yesterday’s big winner, lithium explorer Forrestania Resources (ASX:FRS), has given back a chunk of its gains following the release of an updated announcement late yesterday afternoon.